MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR
...majority was female. More than one-third of the patients used Avonex as index medication, while others used Copaxone (31 percent), Rebif (17 percent), betaseron
(14 percent) and Tysabri (less than 1 percent).
HealthCore, based in Wilmington, Del., is the clinical outcomes research sub...
New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
...esults showed that early and sustained exposure to betaseron
in study participants with multiple sclerosis (MS)... study, early initiation and sustained exposure to betaseron
were strongly associated with a reduced risk of a ...d the potential for long-term benefits of starting betaseron
treatment early and staying on therapy, even after...
Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals
...ts of the BETAPLUS(TM)(b) program
that patients on betaseron
can sign up for. It was a great relief and
allowed...thCare Pharmaceuticals Inc.(1)
(Interferon beta-1b) is indicated for the treatmen...jections, product formulation and patient support. betaseron
requires half as many injections as Copaxo...
Large Study Shows that Presence of Neutralizing Antibodies Did Not
Predict Clinical Response to Betaseron Treatment
WAYNE, N.J., April 02, 2007 /PRNewswire/ -- Berlex, Inc., a U.S.
affiliate of Bayer Schering Pharma AG, Germany, announced today the
results of a retrospective study demonstrating that the presence of
neutralizing antibodies (NAbs) that can develop in response to
Betaseron(R) (interferon beta-1b) ...
First of Its Kind Data Show: Immediate Treatment of Early MS
Patients with Betaseron Significantly Delayed Permanent Disability
Risk to confirmed EDSS progression reduced by 40 percent compared
to delayed treatment
BOSTON, May 01, 2007 /PRNewswire/ -- Bayer HealthCare
Pharmaceuticals announced today new data, which show that immediate
initiation(1) of Betaseron(R) (interferon beta-1b) treatment in
patients with a first eve...
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
...m a continued benefit of initiating treatment
shortly after the first event.(1) These five-year ... study also demonstrated that early treatment with betaseron
beneficial effect on cognition that became e...re from the workforce. Patients treated early
fared better in tests of cognitive function compar...
New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
...arlier treatment initiation and longer exposure to betaseron
associated with improved long-term outcomes in...data
from the 16-Year Long-Term Follow-up Study of betaseron
to investigate the
relationship between timing of ...(diagnosed within two years) who were treated with betaseron
assessed every six months using tests to measu...
Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
...with the disease start an effective treatment
right away, rather than wait for further clinical ...ated or relapse-related outcomes in the trial. -- betaseron
was safe and well-tolerated, with the reporting of...entered the follow-up study elected to receive betaseron
treatment, indicating high patient acceptance of ...
Immediate Treatment of Early MS Patients with Betaferon
Significantly Delayed Permanent Disability
follow up of people treated with Betaferon® has shown that it
is safe and well tolerated.
*Mark S. Freedman, et al: betaseron
in Newly Emerging Multiple
Sclerosis for Initial Treatment (BENEFIT): Effects of Immediate vs.
Early Onset of Interferon Beta-1b Treatment, American A...
Studies Presented at Neurology Conference Highlight Early Efficacy,
Long-Term Tolerability, and High Patient Satisfaction with
...after two years.
The second study - known as the betaseron
Follow-up (16- Year LTF) Study(3... of MS who had already participated
in the pivotal betaseron
trial, the results of which led to the
drug's approval in 1993. The long-term use of betaseron
associated with a delay of clinically signific...
Annual Meeting of the Consortium of Multiple Sclerosis Centers
Focuses on the Challenges of Care and Research in Multiple
... from pharmaceutical intervention. Results showed that
prompt initiation of betaseron
treatment in patients with a first
MS attack was associated with a 40 perce...rly treatment is desirable in MS to avoid or
diminish long-term disability. betaseron
is approved for the
treatment of relapsing forms of MS to reduce the freque...